IngentaConnect Induction of T `regulatory' cells by standardized house dust mite...

Abstract:

Summary Background

Clinically effective subcutaneous allergen-specific immunotherapy (SIT) is associated with altered circulating T cell cytokine production and altered local cytokine responses with increased IL-10 following allergen challenge in target organs. Objective

This study aimed to elucidate mechanisms for these T cell changes, by examining surface expression of markers for peripheral tissue trafficking on circulating cytokine-positive T cells following standardized house dust mite- (HDM-) SIT. Methods

A randomized conventional HDM immunotherapy study was performed on a panel of 12 HDM-allergic subjects. Nine subjects received treatment with conventional HDM immunotherapy using a standardized extract and three subjects were treated by standard pharmacotherapy alone. Symptom and medication scores and allergen-induced cutaneous late-phase responses were assessed before and 9 months after institution of therapy. Before and at 3 and 9 months of SIT, peripheral blood mononuclear cells were cultured for 14 days with HDM extract and CD4⁺ and CD8⁺ T cell expression of CD62L, CD49d and CCR5 and production of IL-10, IFN- gamma

and IL-4 were analysed by flow cytometry. Allergen-specific T cell proliferation was assessed by ³H-thymidine incorporation. Results

At 9 months, all SIT-treated patients showed reduced symptom scores and late-phase cutaneous responses to HDM compared with baseline levels. The proportions of CD4⁺ T cells which were IL-10⁺ were increased (P<0.01), and the proportions of CD4⁺ and CD8⁺ T cells which were IL-4⁺ decreased (P<0.05) compared with baseline. CD4⁺ and CD8⁺ T cell IFN- gamma

production, expression of surface markers for peripheral tissue trafficking and allergen-specific proliferation remained unchanged during SIT treatment. However, increased proportions of CD4⁺CD62L^-, CD4⁺CD49d^hi, CD4⁺CCR5⁺ T cells expressing IL-10 were detected at 9 months of SIT compared with baseline (P<0.05). IL-10 staining co-localized with CD4⁺CD25⁺ T cells. Conclusion

Clinically effective subcutaneous immunotherapy with a standardized HDM Dermatophagoides pteronyssinus preparation results in decreased numbers of IL-4⁺ T cells and expansion of CD4⁺IL-10⁺ T cells expressing a peripheral tissue trafficking phenotype. The co-localization of IL-10⁺ staining to CD4⁺CD25⁺ T cells is consistent with the induction of a T regulatory cell population by SIT.

Keywords: adhesion molecules; allergy; CD4+CD25+ T cell; chemokine receptor; house dust mite; IFN- gamma ; IL-4; IL-10; specific immunotherapy; T regulatory cell

Document Type: Research article

DOI: 10.1111/j.1365-2222.2004.02009.x

Affiliations: 1: Department of Pathology and Immunology, Monash University and 2: Department of Allergy, Immunology and Respiratory Medicine, the Alfred Hospital and Monash University, Melbourne, Victoria, Australia

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax Refund Policy

Induction of T ‘regulatory’ cells by standardized house dust mite immunotherapy: an increase in CD4+CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers

Induction of T ‘regulatory’ cells by standardized house dust mite immunotherapy: an increase in CD4⁺CD25⁺ interleukin-10⁺ T cells expressing peripheral tissue trafficking markers